NYSE · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · SMALL CAP
Concord Medical Services Holdings Ltd. CCM
17 fiscal years on record · CNY · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in Concord Medical Services Holdings Ltd's annual report to the U.S. Securities and Exchange Commission, filed 29 April 2026. Every sentence was checked against that document before publication.
Growth
CNY 460.5M
Revenue, FY2025 · full 17-year series below
Revenue CNY M
Net income CNY M
FY2025 · Revenue 460.5 · Net income -92.8
Compound annual growth
Revenue compounded at +15.6% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−82 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -56.8% · Net -82.4%
ROE
FY2019 · ROE -195.2%
The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · CNY
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue CNY B | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.2 | 0.2 | 0.2 | 0.3 | 0.5 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.4 | 0.3 |
| Operating income CNY B | −0.3 | −0.5 | −0.5 | −0.5 | −0.5 | −0.3 | −0.4 | −0.3 | −0.2 | −0.2 | −0.0 | 0.2 | 0.2 | 0.2 | −0.2 | 0.2 | 0.2 |
| EBITDA CNY B | −0.2 | −0.4 | −0.4 | −0.4 | −0.4 | −0.3 | −0.4 | −0.3 | −0.1 | −0.1 | 0.1 | 0.4 | 0.3 | 0.3 | −0.1 | 0.3 | 0.2 |
| Income tax CNY B | 0.0 | −0.0 | −0.0 | −0.1 | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Net income CNY B | −0.1 | −0.3 | −0.3 | −0.5 | −0.3 | −0.3 | −0.3 | −0.2 | −0.3 | −0.3 | −0.1 | 0.1 | 0.1 | 0.1 | −0.2 | 0.1 | 0.0 |
| Free cash flow CNY B | −0.3 | −0.5 | −0.4 | −0.4 | −0.6 | −0.4 | −0.4 | −0.2 | −0.1 | −0.2 | −0.2 | 0.4 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 |
| EPS, diluted CNY | −0.71 | −2.35 | −2.27 | −3.74 | −6.26 | −5.11 | −4.24 | −2.76 | −2.19 | −2.00 | −0.58 | 0.92 | 0.64 | 0.95 | −1.51 | 0.89 | 0.62 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | · | · |
| Payout % | · | · | · | · | · | · | · | −0 | −0 | −109 | −0 | 364 | · | · | −26 | · | 35 |
| ROE % | · | · | · | · | · | · | −195.2 | −34.3 | −27.1 | −20.5 | −4.9 | 6.4 | 4.1 | 6.6 | −10.4 | 5.9 | · |
| Shares out B | · | · | · | · | · | · | · | · | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.14 | 0.14 | 0.14 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Compare
This company against its peers
Provenance
Company facts, as filed
How we verify · 5 failures in 82 reconciliationsAUDITED
Reconciled in 12 of 19 fiscal years. 13 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente5 failures
ActivityServices-Offices & Clinics of Doctors of Medicine
Listed onNYSE
Incorporated inoutside the United States — SEC code E9
Fiscal year endsnot stated in the filings
Data on record since2009